DRUG-DRUG INTERACTION OF LY2623091 WITH CYP3A INHIBITORS ITRACONAZOLE (ITR) AND DILTIAZEM (DIL) AND THE STEADY STATE PHARMACOKINETICS OF ITRACONAZOLE

Dickinson G. L.; Phillips D. L.; Posada M. M.; Chaudhary A.; Hall S. D.

首页> 外文期刊>Clinical Pharmacology and Therapeutics >DRUG-DRUG INTERACTION OF LY2623091 WITH CYP3A INHIBITORS ITRACONAZOLE (ITR) AND DILTIAZEM (DIL) AND THE STEADY STATE PHARMACOKINETICS OF ITRACONAZOLE

【24h】

DRUG-DRUG INTERACTION OF LY2623091 WITH CYP3A INHIBITORS ITRACONAZOLE (ITR) AND DILTIAZEM (DIL) AND THE STEADY STATE PHARMACOKINETICS OF ITRACONAZOLE

机译：LY2623091与CYP3A抑制剂依他康唑（ITR）和Diltiazem（DIL）的药物相互作用和依他康唑的稳态药代动力学

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Clinical Pharmacology and Therapeutics》 |2016年第1期|共1页
作者
Dickinson G. L.; Phillips D. L.; Posada M. M.; Chaudhary A.; Hall S. D.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. DRUG-DRUG INTERACTION OF LY2623091 WITH CYP3A INHIBITORS ITRACONAZOLE (ITR) AND DILTIAZEM (DIL) AND THE STEADY STATE PHARMACOKINETICS OF ITRACONAZOLE [J] . Dickinson G. L., Phillips D. L., Posada M. M., Clinical Pharmacology and Therapeutics . 2016,第Suppla1期

机译：LY2623091与CYP3A抑制剂依他康唑（ITR）和Diltiazem（DIL）的药物相互作用和依他康唑的稳态药代动力学
2. DRUG-DRUG INTERACTION STUDY OF INCB050465 WITH CYP3A4 INHIBITOR ITRACONAZOLE AND INDUCER RIFAMPIN IN HEALTHY VOLUNTEERS. [J] . Li J., Rockich K., Epstein N., Clinical Pharmacology and Therapeutics . 2019,第Suppla1期

机译：CYP3A4抑制剂Itraconazole和诱导型志愿者中Inc.3A4抑制剂Itraconazole的药物 - 药物相互作用研究。
3. Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WB-PBPK) models [J] . Michaela Vossen, Michael Sevestre, Christoph Niederalt, Theoretical Biology and Medical Modelling . 2007,第1期

机译：使用个体偶联全身基于生理的药代动力学（WB-PBPK）模型动态模拟咪达唑仑和CYP3A4抑制剂伊曲康唑的相互作用
4. A semi-mechanistic pharmacokinetic model of saquinavir combined with itraconazole in HIV-1-positive patients [C] . Lohitnavy Manupat, Methaneethorn Janthima, Sriarwut Thanyalak, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2015

机译：沙奎那韦联合伊曲康唑在HIV-1阳性患者中的半机制药代动力学模型
5. Effect of the tight junction modulator Zonula occludens toxin (Zot) and the P-glycoprotein inhibitor itraconazole on brain transport enhancement and their potential for renal drug interactions [D] . Karyekar, Chetan S. 2002

机译：紧密连接调节剂Zonula咬合毒素（Zot）和P-糖蛋白抑制剂伊曲康唑对脑转运增强的作用及其与肾脏药物相互作用的潜力
6. Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WB-PBPK) models [O] . Michaela Vossen, Michael Sevestre, Christoph Niederalt, 2007

机译：使用个体偶联全身基于生理的药代动力学（WB-PBPK）模型动态模拟咪达唑仑和CYP3A4抑制剂伊曲康唑的相互作用
7. Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WB-PBPK) models [O] . 2007

机译：使用个体偶联全身基于生理的药代动力学（WB-PBPK）模型动态模拟咪达唑仑和CYP3A4抑制剂伊曲康唑的相互作用

DRUG-DRUG INTERACTION OF LY2623091 WITH CYP3A INHIBITORS ITRACONAZOLE (ITR) AND DILTIAZEM (DIL) AND THE STEADY STATE PHARMACOKINETICS OF ITRACONAZOLE

著录项

引文网络

相似文献

相关主题

期刊订阅